Biologics
Simcere Zaiming Doses First U.S. Patient in Phase 1 Trial of Trispecific Antibody SIM0500 for Relapsed/Refractory Multiple Myeloma
Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group announced the first US patient has started treatment in the ongo...
June 19, 2025 | News
Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts
Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...
June 19, 2025 | News
NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations
Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% NEC Corporation (NEC; TSE: ...
June 19, 2025 | News
Terumo BCT Showcases 3-in-1 CAR-T Manufacturing Protocol in Cytotherapy
Protocol published in Cytotherapy1 shows activation and viral transduction can be performed on Terumo BCT’s Quantum Cell Expansion System.&nbs...
June 19, 2025 | News
RemeGen’s Telitacicept Secures EMA Orphan Drug Designation for Myasthenia Gravis, Advancing Global Development
RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Desig...
June 18, 2025 | News
Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for Lung Cancer
Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of Scorpion Therapeutics, Inc., o...
June 17, 2025 | News
BioDlink Secures NAFDAC Approval for Bevacizumab Injection, Marking Strategic Entry into the African Market
BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration an...
June 17, 2025 | News
Teva and Fosun Pharma Enter Strategic Partnership to Advance Anti-PD1-IL2 ATTENUKINE™ Therapy TEV-56278 for Oncology
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun...
June 17, 2025 | News
HELP Therapeutics and China Resources Sanjiu Forge Strategic Partnership to Advance Groundbreaking iPSC-Derived Therapy for Heart Failure in China
HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceut...
June 17, 2025 | News
Abbisko Begins Registrational Trial of Irpagratinib, a Precision FGFR4 Inhibitor, for Advanced Liver Cancer
Abbisko Therapeutics announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective ...
June 17, 2025 | News
Debiopharm and Alkyon Therapeutics Join Forces to Advance Precision Radioligand Cancer Therapies
Research program combining Debiopharm’s AbYlink™ conjugation technology with Alkyon’s modular antibody platform and novel targeting app...
June 16, 2025 | News
Aragen to Launch GMP Biologics Manufacturing in India by July 2025
Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biol...
June 16, 2025 | News
Visterra Licenses Nona Biosciences’ HCAb Harbour Mice® Platform to Advance Autoimmune Biotherapeutics
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreeme...
June 13, 2025 | News
Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...
June 13, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
